{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T05:10:19Z","timestamp":1779426619341,"version":"3.53.1"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"publisher","award":["24-73-10199"],"award-info":[{"award-number":["24-73-10199"]}],"id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.bmc.2026.118615","type":"journal-article","created":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T01:51:49Z","timestamp":1772848309000},"page":"118615","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Synthesis and evaluation of new 2-substituted anthra[2,3-b]furan-5,10-diones: tumor cell apoptosis through DNA binding and topoisomerases inhibition"],"prefix":"10.1016","volume":"137","author":[{"given":"Alexander S.","family":"Tikhomirov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lyubov G.","family":"Dezhenkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulia L.","family":"Volodina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dmitry N.","family":"Kaluzhny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Schols","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrey E.","family":"Shchekotikhin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2026.118615_bb0005","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2174\/1574892813666171206123114","article-title":"Advances in the discovery of anthraquinone-based anticancer drugs","volume":"13","author":"Tikhomirov","year":"2018","journal-title":"Recent Pat Anticancer Drug Discov"},{"key":"10.1016\/j.bmc.2026.118615_bb0010","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1002\/cmdc.202000131","article-title":"Antitumour anthracyclines: progress and perspectives","volume":"15","author":"Martins-Teixeira","year":"2020","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bmc.2026.118615_bb0015","doi-asserted-by":"crossref","first-page":"627","DOI":"10.4155\/fmc-2019-0322","article-title":"Novel anthraquinone compounds as anticancer agents and their potential mechanism","volume":"12","author":"Tian","year":"2020","journal-title":"Future Med Chem"},{"key":"10.1016\/j.bmc.2026.118615_bb0020","doi-asserted-by":"crossref","first-page":"3624","DOI":"10.1039\/C9NJ03817E","article-title":"Design and synthesis of a peptide derivative of ametantrone targeting the major groove of the d(GGCGCC)2 palindromic sequence","volume":"44","author":"Ongaro","year":"2020","journal-title":"New J Chem"},{"key":"10.1016\/j.bmc.2026.118615_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.rechem.2024.101324","article-title":"Spectroscopy and calorimetry evidence of binding-induced thermal stabilization of human telomeric G-quadruplex DNA by 1,5-disubstituted morpholino-amido anthraquinone: molecular basis of anticancer action","volume":"7","author":"Kumari","year":"2024","journal-title":"Results Chem"},{"key":"10.1016\/j.bmc.2026.118615_bb0030","doi-asserted-by":"crossref","DOI":"10.1038\/srep39456","article-title":"Mitoxantrone and analogues bind and stabilize i-motif forming DNA sequences","volume":"6","author":"Wright","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.bmc.2026.118615_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2025.130347","article-title":"Discovery of anthraquinone-triazene derivatives as novel antitumor agents causing DNA damage","volume":"128","author":"Jia","year":"2025","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmc.2026.118615_bb0040","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14194719","article-title":"Bis(chloroacetamidino)-derived heteroarene-fused anthraquinones bind to and cause proteasomal degradation of tNOX, leading to c-Flip downregulation and apoptosis in oral cancer cells","volume":"14","author":"Chang","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.bmc.2026.118615_bb0045","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1248\/cpb.c20-00206","article-title":"A series of novel HDAC inhibitors with anthraquinone as a cap group","volume":"68","author":"Zou","year":"2020","journal-title":"Chem Pharm Bull"},{"key":"10.1016\/j.bmc.2026.118615_bb0050","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.carres.2018.02.012","article-title":"Synthesis of novel sugar or azasugar modified anthra[1,2-d]imidazole-6,11-dione derivatives and biological evaluation","volume":"460","author":"Wang","year":"2018","journal-title":"Carbohydr Res"},{"key":"10.1016\/j.bmc.2026.118615_bb0055","doi-asserted-by":"crossref","first-page":"11922","DOI":"10.18632\/oncotarget.23714","article-title":"Identification and preclinical evaluation of the small molecule, NSC745887, for treating glioblastomas via suppressing DcR3- associated signaling pathways","volume":"9","author":"Fann","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.bmc.2026.118615_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116222","article-title":"Thiadiazole-, selenadiazole- and triazole-fused anthraquinones as G-quadruplex targeting anticancer compounds","volume":"268","author":"Andreeva","year":"2024","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2026.118615_bb0065","doi-asserted-by":"crossref","first-page":"9522","DOI":"10.1021\/acs.jmedchem.5b00859","article-title":"Synthesis and characterization of 4,11-diaminoanthra[2,3-b]furan-5,10-diones: tumor cell apoptosis through tNOX-modulated NAD+\/NADH ratio and SIRT1","volume":"58","author":"Tikhomirov","year":"2015","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2026.118615_bb0070","doi-asserted-by":"crossref","DOI":"10.1002\/slct.202405166","article-title":"Computational study on anthrapyrazoles, anthraisoxazoles, and proposed anthraisothiazoles: DFT and molecular docking analysis","volume":"10","author":"Patil","year":"2025","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.bmc.2026.118615_bb0075","doi-asserted-by":"crossref","unstructured":"M. Singh, L. Malhotra, M.A. Haque, M. A., M., M. Kumar, A.S. Tikhomirov, V.A. Litvinova, A.M. Korolev, A.S. Ethayathulla, U. Das, A.E. Shchekotikhin, P. Kaur, Heteroarene-fused anthraquinone derivatives as potential modulators for human aurora kinase B, Biochimie 182 (2021) 152\u2013165, doi;https:\/\/doi.org\/10.1016\/j.biochi.2020.12.024.","DOI":"10.1016\/j.biochi.2020.12.024"},{"key":"10.1016\/j.bmc.2026.118615_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112294","article-title":"Amides of pyrrole- and thiophene-fused anthraquinone derivatives: a role of the heterocyclic core in antitumor properties","volume":"199","author":"Tikhomirov","year":"2020","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2026.118615_bb0085","doi-asserted-by":"crossref","DOI":"10.3390\/ph13050081","article-title":"Experimental evaluation of anti-cancer efficiency and acute toxicity of Anthrafuran for oral administration","volume":"13","author":"Shchekotikhin","year":"2020","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.bmc.2026.118615_bb0090","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.ejmech.2010.11.017","article-title":"The first series of 4,11-bis[(2-aminoethyl)amino]anthra[2,3-b]furan-5,10-diones: synthesis and antiproliferative characteristics","volume":"46","author":"Shchekotikhin","year":"2011","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2026.118615_bb0095","doi-asserted-by":"crossref","first-page":"9448","DOI":"10.1021\/acs.jmedchem.7b00622","article-title":"RNA G-quadruplexes in Kirsten Ras (KRAS) oncogene as targets for small molecules inhibiting translation","volume":"60","author":"Miglietta","year":"2017","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2026.118615_bb0100","doi-asserted-by":"crossref","first-page":"8062","DOI":"10.1016\/j.tet.2014.08.033","article-title":"Pd-catalyzed cross-coupling\/heterocyclization domino reaction: facile access to anthra[2,3-b]furan-5,10-dione scaffold","volume":"70","author":"Tikhomirov","year":"2014","journal-title":"Tetrahedron"},{"key":"10.1016\/j.bmc.2026.118615_bb0105","doi-asserted-by":"crossref","DOI":"10.59761\/RCR5141","article-title":"Methods for functionalization of anthraquinones","volume":"93","author":"Litvinova","year":"2024","journal-title":"Russ Chem Rev"},{"key":"10.1016\/j.bmc.2026.118615_bb0110","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222312827","article-title":"The MTT assay: utility, limitations, pitfalls, and interpretation in bulk and single-cell analysis","volume":"22","author":"Ghasemi","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.bmc.2026.118615_bb0115","doi-asserted-by":"crossref","first-page":"11390","DOI":"10.1021\/acs.jmedchem.3c00853","article-title":"Re-exploring the anthracycline chemical space for better anti-cancer compounds","volume":"66","author":"van Gelder","year":"2023","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2026.118615_bb0120","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/BF00686403","article-title":"Doxorubicin inhibits human DNA topoisomerase I","volume":"30","author":"Foglesong","year":"1992","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.bmc.2026.118615_bb0125","doi-asserted-by":"crossref","DOI":"10.3390\/ph16101456","article-title":"Prospects of topoisomerase inhibitors as promising anti-cancer agents","volume":"16","author":"Yakkala","year":"2023","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.bmc.2026.118615_bb0130","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1016\/S0968-0896(01)00243-7","article-title":"Thiazole orange as the fluorescent intercalator in a high resolution fid assay for determining DNA binding affinity and sequence selectivity of small molecules","volume":"9","author":"Boger","year":"2001","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2026.118615_bb0135","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26092828","article-title":"Broad applications of thiazole orange in fluorescent sensing of biomolecules and ions","volume":"26","author":"Suss","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.bmc.2026.118615_bb0140","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1146\/annurev-biochem-091724-010717","article-title":"Topoisomerase regulation of Cancer gene expression","volume":"94","author":"Baranello","year":"2025","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.bmc.2026.118615_bb0145","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19113480","article-title":"Anthracyclines as topoisomerase II poisons: from early studies to new perspectives","volume":"19","author":"Marinello","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.bmc.2026.118615_bb0150","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1021\/acs.bioconjchem.9b00112","article-title":"Trapped! A critical evaluation of methods for measuring total cellular uptake versus cytosolic localization","volume":"30","author":"Deprey","year":"2019","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.bmc.2026.118615_bb0155","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1089\/ars.2023.0445","article-title":"Reactive oxygen species modulation in the current landscape of anticancer therapies","volume":"41","author":"Li","year":"2024","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.bmc.2026.118615_bb0160","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1406247","article-title":"An update of the molecular mechanisms underlying anthracycline induced cardiotoxicity","volume":"15","author":"Xie","year":"2024","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.bmc.2026.118615_bb0165","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1007\/s00204-016-1759-y","article-title":"Pathways of cardiac toxicity: comparison between chemotherapeutic drugs doxorubicin and mitoxantrone","volume":"90","author":"Damiani","year":"2016","journal-title":"Arch Toxicol"},{"key":"10.1016\/j.bmc.2026.118615_bb0170","series-title":"DNA Repair Protocols. Methods in Molecular Biology, vol Vol. 920","article-title":"Histone H2AX phosphorylation: A marker for DNA damage","author":"Sharma","year":"2012"}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089626000714?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089626000714?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T04:58:07Z","timestamp":1779425887000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089626000714"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":34,"alternative-id":["S0968089626000714"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2026.118615","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis and evaluation of new 2-substituted anthra[2,3-b]furan-5,10-diones: tumor cell apoptosis through DNA binding and topoisomerases inhibition","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2026.118615","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118615"}}